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Bovine ephemeral fever (BEF) has been recorded in China since 1950, 
with morbidity reaching 40% during epidemics. Accordingly, the disease 
has been given high priority by Chinese authorities, as the development of 
cattle and buffalo industries is a major objective of the government. 
Similarly, the promotion of animal-based industries and the potential 
impact of bluetongue disease on small ruminants resulted in this condition 
being the subject of intensive research in southern China, particularly in 
Yunnan province.
These diseases cause direct economic losses, firstly because of animal 
mortality and morbidity during outbreaks, and secondly because trade in 
valuable breeding stock is curtailed by costly laboratory testing for the 
presence of diseases. China has strict quarantine testing requirements 
relating to bluetongue. These impede the movement of animals from place 
to place. 
Despite the impact of BEF and bluetongue in China, little was known 
about disease epidemiology, potential for vaccine management and risks 
of introduction. 
As a result of this need for more information, A$3.1 million was invested 
in ACIAR-supported research designed to better understand these diseases 
and develop a vaccine-based approach to their control. Information 
generated from the projects has led to the development of a successful and 
widely used vaccine for BEF. Also, no cases of bluetongue have been 
reported since 1997 when bluetongue project work ended. Furthermore, it 
is possible that Chinese import-testing requirements for live animals could 
be rationalised in the longer term, in part as an outcome of research 
undertaken in the projects, the results of which led to a better 
understanding of these diseases. 
Based on levels of disease prevalence reported at the beginning of the 
projects, ACIAR BEF and bluetongue research investments are forecast to 
generate a net present value of A$4.6 million. It is estimated that Chinese 
cattle producers will capture approximately 90% of these benefits. 
Benefits to Australian exporters could be significantly larger in the longer 
term, but are uncertain given the political nature of trade regulations, and 
hence have not been included in the analysis. A benefit–cost ratio of 2.3:1 
was estimated for the projects; that is, for each dollar invested, 2.3 dollars 
of project benefits will be generated. 
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In addition to possible direct cost savings to Australian animal exporters 
and animal productivity benefits for Chinese livestock producers, several 
non-economic benefits have been realised. These include a valuable 
enhancement of the body of scientific knowledge about these important 
animal diseases, and the organisation of international symposia to 
disseminate project findings.  
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Bluetongue and bovine ephemeral fever (BEF) are vector-borne viral 
diseases transmitted to cattle, buffalo, sheep and goats by biting insects. 
During outbreaks of BEF in China, morbidity has been as high as 40% and 
mortality up to 5% (Wenbin 1993). Draught cattle have a prolonged 
convalescence, disrupting the farming system, and milk losses occur in 
animals that recover from the disease. Clinical signs of bluetongue are 
typically observed only in sheep, and vary depending on the virus strain and 
the type of livestock. Sheep mortality can be very high in affected animals, 
and animals that survive the disease produce less meat and wool. In addition 
to direct production losses, the presence of these diseases restricts trade in 
breeding animals. Such restrictions retard the injection of genetically 
improved livestock into China’s animal industries and impose high testing 
costs on those wishing to export animals to China. 
Outbreaks of bluetongue were first documented in China during the late 
1970s, while BEF had been recorded since 1950. Major outbreaks had 
occurred in a number of provinces, with Zhejiang, Liaoning, Shandong 
and Guangdong being the provinces where the BEF was most often 
observed (Wenbin 1993). Despite the economic impact of these diseases, 
very little was known about disease epidemiology, potential for 
management using vaccines, and risks of introduction and transmission.
Considerable BEF research expertise was centred at the then CSIRO 
Division of Tropical Animal Production (now CSIRO Livestock 
Industries) in Australia, and bluetongue expertise was located at the NSW 
Department of Agriculture. To develop serological tests to better 
understand disease epidemiology and pathogenesis, a series of research 
projects was commenced in the mid 1980s. The overarching aim of the 
investment in the ACIAR projects was to reduce the impact of the two 
diseases. The series of projects included:
 
       
 
Epidemiology of bovine ephemeral fever in China (AS1/1984/055)
 
       
 
Improved methods for the diagnosis and control of bluetongue in 
small ruminants in Asia (AS2/1990/011)
 
       
 
Studies of the epidemiology and control of bluetongue in China 
(AS2/1993/001).
In total, A$3.1 million (nominal terms) was invested in the ACIAR-
supported projects in Asia and Australia across the life of the projects. As a  
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result, diagnostic tools were adopted in regional laboratories, a killed BEF 
vaccine has been developed and animal exportation requirements for 
Australian livestock destined for China might be rationalised in the future. 
Since completion of the bluetongue projects there have been no recorded 
cases of the disease in China. Similarly for BEF, there have been no major 
epidemics in China since the end of the ACIAR-financed research. 
The killed BEF vaccine, to the development of which the ACIAR research 
contributed, is administered to approximately 100,000 cattle per year in 
China, leading to reduced disease incidence and increased animal 
productivity. The killed BEF vaccine differs from the live vaccine used in 
Australia (and used on a small scale in China before the projects) in that 
the virus is inactivated and cannot replicate. Such a vaccine is more 
straightforward to administer and does not have the cold storage and 
handling problems associated with live vaccines. 
The economic benefits to China from BEF vaccine development, and 
possible benefits to Australian exporters from reduced export testing 
costs, are quantified in this benefit–cost assessment. The killed BEF 
vaccine was commercialised in the mid-1990s and, to date, benefits to 
only Chinese cattle producers have been realised. Potential benefits to 
Australian exporters from changes to export testing have yet to be 
captured.
 
2 The ACIAR projects and their 
outputs
 
The three projects evaluated in this report began in the 1986 financial year, 
as project AS1/1984/055, Epidemiology of ephemeral fever in China. The 
outputs of this and the following projects are described in this section. 
 
2.1 Epidemiology of bovine ephemeral fever in China 
(AS1/1984/055)
 
This project involved collaboration between the CSIRO Division of 
Tropical Animal Production and the Harbin Veterinary Research Institute 
(HVRI) in China. HVRI is one of the leading veterinary research institutes 
in China and this project was its first with a foreign country. The research, 
which began in October 1985, had the following objectives: 
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develop a highly specific serological test capable of distinguishing 












monitor BEF infection by serum surveys and sentinel herds.
The project termination report indicates that the basic technologies for 
virology, serology and some biochemical techniques were established at 
HVRI through the combination of visits and collaboration associated with 
the project. The neutralisation tests for BEF were used to establish surveys 
of disease presence in China. Additionally, a serum bank, a sentinel herd 
system to study disease epidemiology and computer systems were 
established at the institute. A blocking enzyme-linked immunosorbent 
assay (ELISA) test based on monoclonal antibodies was developed and 
implemented at HVRI. This test is a highly specific and sensitive test for 
diagnosing BEF. 
An experiment was conducted in Guangdong province by scientists of 
both countries to investigate the pathogenicity of BEF in buffalo. The 
virus caused reactions in buffalo similar to those in cattle, but milder. The 
test highlighted the need to use buffalo strains of the virus. 
Insect collecting demonstrated that the vectors of the disease existed as far 
north as Harbin. 
Research on the chemistry of the virus revealed that the Beijing strain 
contained at least four proteins and was similar to Australian isolates.
This research laid the foundations for improving and developing killed BEF 
vaccines in China. Based on the results of the project, specifically the 
development of diagnostic methods for BEF serum and of improved cell 
culture techniques, HVRI prepared a BEF killed vaccine. This vaccine is 
now used by many intensive cattle enterprises in China. The monetary 
benefits of this are quantified in the economic evaluation section. Before the 
ACIAR project, a live vaccine imported from Australia and one developed 
in China were used on a small scale. These vaccines were shown to confer 
low levels of immunity or to have detrimental side effects (Wenbin et al. 
1993), and were not widely adopted by Chinese livestock producers. 
9
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2.2 Improved methods for the diagnosis and control 
of bluetongue in small ruminants in Asia 
(AS2/1990/011)
 
During the early 1990s, Malaysian authorities sought to increase the 
national sheep flock from 80,000 to 1–2 million head by the end of the 
century. Sheep were seen as a valuable component of integrated plantation 
production systems, acting as a source of revenue, increasing rural sector 
employment, reducing the need for herbicide, enhancing soil fertility and 
helping to manage biomass in plantations. Sheep from Australia were a 
possible source of breeding stock for the build-up in sheep numbers. 
However, the presence of bluetongue constrained the development of the 
Malaysian sheep industry. 
Australian veterinarians were experienced in dealing with bluetongue, and 
this led to the implementation of project AS2/1000/011 in January 1991, 
with the aim of better managing the disease. The project involved 
collaboration between the Australian Government’s Bureau of Rural 
Resources, the Queensland Department of Primary Industries and the 





introduction of virus isolation and serological research and 
investigation of techniques using Australian and field materials 




using the techniques and cell cultures established within the first 








framing and initiating research projects to investigate the ecology and 
control of bluetongue in Malaysia.
The external review of the ACIAR project indicated that the primary project 
objectives were met. The Veterinary Research Institute at Ipoh now has agar 
gel immunodiffusion, ELISA, cell culture, micro neutralisation, plaque 
reduction and polymerase chain reaction (PCR) tests for the detection of 
both viruses and antibodies. Bluetongue viruses were isolated from 
experimental herds, and bluetongue testing was introduced as a routine 
procedure at the laboratory. In addition to training staff in Malaysia, an 
international training workshop was held at which personnel from India, 
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Limited serological studies were conducted, while isolations and reports 
of clinical disease provided some evidence of disease seasonality. The 
shortness of the project prevented comprehensive vector studies. 
Following the research, the institute at Ipoh was able to undertake 
ecological studies, during which disease management recommendations 
could be synthesised. The project review report noted that Malaysian 
authorities had reduced the incidence of the disease by curtailing 
importation of susceptible sheep from Australia and New Zealand. The 
replacement imports, mainly from Thailand, appear to be less susceptible 
to bluetongue. Since this project has been completed, the Malaysian 
national flock has not grown as expected. Consequently, any economic 
benefits derived from the improved control of the disease are likely to be 
small, and any possible benefits associated with bluetongue management 
in that country are not included.
 
2.3 Studies of the epidemiology and control of 
bluetongue in China (AS2/1993/001)
 
Bluetongue was first detected in China in 1979, at a sheep-breeding farm 
in northern Yunnan province. Since then, the disease has been recorded in 
several other provinces and its control was given high priority in Chinese 
national planning. Australian scientists had been investigating bluetongue 
since 1977, and considerable expertise existed in the NSW Department of 
Agriculture and at CSIRO. At the request of the Chinese Government, a 
delegation from the Yunnan Animal Husbandry Bureau visited Australia 
in 1991, with the aim of developing a project to better manage the disease. 









improve laboratory capabilities for the diagnosis of bluetongue virus 








gain recognition of the new Yunnan Tropical and Subtropical Animal 




isolate and characterise viruses from outbreaks of suspected 




examine serum samples from sentinel animals for the occurrence of 
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To develop disease-control programs, the epidemiology and pathogenesis 
of a disease needs to be understood. The development of laboratory 
capability, along with diagnostic tool (ELISA) introduction, underpins the 
implementation of a rational disease-management program. A sensitive c-
ELISA test for detecting bluetongue antibody positive animals, and an 
efficient virus isolation protocol, were developed within this project. The 
protocol is based on chicken embryo inoculations, but employs the antigen 
detection ELISA to confirm presence of bluetongue. This procedure 
increases the efficiency of bluetongue isolation manyfold and speeds up 
accurate diagnosis.
The project had a large training component in general laboratory and 
sentinel herd establishment practices. The review team appointed by 
ACIAR to determine if the project had met its stated objectives was very 
impressed with the level of training achieved. The scientific methodology 
for sentinel herds is based on the strategy used in Australia. Systems for 
virus and serum storage and recording, suitability of serum samples for 
testing, organised result recording, and maintenance of laboratory and 
reagent supplies were implemented, along with new, general laboratory 
practices. Even during 1996, when large numbers of samples were tested 
serologically and a large number of viruses was isolated, technical and 
scientific scrutiny were maintained. The development of diagnostic 
capability helps identify bluetongue outbreaks and the types of serotypes 
involved. As such, the information is used to direct vaccination campaigns 
and reduces the risk of an outbreak of the disease. Bluetongue vaccination 
has been undertaken for some time in China. Diagnostic research 
undertaken as part of this project will help to better manage the disease. 
Early vaccine development in China was based on limited knowledge of 
disease serology. As a result of the project, and identification of serotypes, 
the number of vaccines used to control bluetongue was reduced. Since 
project completion no cases of bluetongue have been reported in China.
Tests and procedures developed within the ACIAR projects also have 
benefits for Australia. The bluetongue testing required of ruminants for 
export to China is expensive and restricts the trade in a potentially large 
market for ruminant livestock. The demonstration of skills by Australian 
scientists, identification of disease types in China and development of 
rapid diagnostic tests for this disease could reduce the costs of animal 
quarantine and testing, with possible future rationalisation of Chinese 
import requirements.  
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3 Realised and potential project 
outcomes
 
Cattle numbers in China have grown from 74 million head in 1988 to 106 
million in 2002 (FAO 2003). Likewise, the sheep flock has grown over 
this period, although growth slowed in the 1990s when wool prices fell. 
Some of the growth in livestock numbers has resulted from the 
importation of high-performance exotic breeds from countries such as 
Australia. These animals are particularly susceptible to diseases such as 
bluetongue and BEF, and can suffer severe production loss if infected.
The Chinese authorities are committed to expanding livestock production, 
and have financed the development of the capacity to handle animal 
diseases across the country. This development included the establishment 
of the Yunnan Tropical and Sub-tropical Animal Virus Diseases 
Laboratory. The realisation of improved diagnostic capability within 
ACIAR-financed BEF and bluetongue projects has reduced the number of 
outbreaks of these diseases. The benefits of this outcome are described in 
this section, firstly by reviewing livestock production in China and then by 
outlining the nature of the bluetongue and BEF disease problems. 
 
3.1  Ruminant production in China
 
Cattle are raised in farmland and pastoral areas in China. Within farmland 
areas, cattle are commonly raised in association with cropping enterprises 
and are used for draught or traction purposes. Extensive pastoral systems 
are found in the western parts of the country, and some of the cattle in this 
region are raised by nomads. Of the 29 provinces in China, approximately 
6 contain areas where cattle are grazed (Tuan 1987). Beef production has 
increased following the rapid increase in national herd size. It should be 
noted that beef production has increased at a rate considerably higher than 
the annual percentage increase in the national herd size. This indicates that 
production per head is increasing as a result of the adoption of higher 
performing livestock (genotypes) and the adoption of more intensive 
management practices.
The Chinese Government has actively promoted dairy development. Tuan 
(1987) reported that, in Heilongjiang province, authorities provided 0.1 ha 
of fodder land and some concentrates with each additional cow raised. 
ADB (1994) reported that in provinces such as Hunan, private dairy herds 
usually comprise about five cows. Poor nutrition has been cited as a major  
13
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constraint on milk yield. In the past, most dairies were state-operated, and 








Considerable progress has been made in improving the performance of the 
local yellow breeds through selection and breeding as dairy cattle, and by 
breeding dual-purpose animals. Dairy cattle were estimated to constitute 
3.5% of the national herd in 1998 (USDA 1998). There are large numbers of 
dairy cattle in the provinces of Nei Monggol, Xinjiang and Heilongjiang. 
The national sheep flock has also increased over the past 14 years. FAO 
(2003) statistics indicate that the flock increased from 103 million in 
1988 to 137 million in 2002. Growth in flock numbers slowed during the 
mid 1990s, in response to low international wool prices. Woolmark 
(2000) indicated that China’s fine-wool sheep numbers fell by 30% 
between 1996 and 2000. In the two key sheep regions—Xinjiang and 
Inner Mongolia—fine sheep numbers declined because growers shifted 
from fine wool production into more profitable meat production. During 
2000, there were about 28 million sheep in Xinjiang, of which 8 million 
were fine wool sheep. These sheep produce approximately 65,000 t 
(greasy weight) of wool per annum. A new, fine-wool flock was being 
developed in 2000 and was expected to produce 800 t of 12–14 µm 
(micron) wool from 200,000 sheep within 5 years (Woolmark 2000). To 
develop the fine wool flocks, exotic breeds, such as those in Australia, 
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3.2  Australian live animal exports
 
LiveCorp (2003) reports that the live animal export industry generated 
A$1.03 billion in revenue during 2002. Live cattle exports represent the 
most important component of the trade, with nearly a million head, valued 
at A$613 million, being exported annually. Live sheep exports were 
valued at A$414.3 million for the 6.1 million head exported. The Middle 
East and North Africa accounted for approximately 60% of the total 
livestock trade. 
Indonesia is Australia’s most substantial customer for exported cattle, 
importing 428,486 head, valued at A$256.7 million, in 2002. This country 
accounts for almost half of the total market. Egypt and the Philippines are 
the second most important countries, with Egypt taking 149,771 head, or 
15.3% of the market, and the Philippines 113,263 head. Malaysia 
imported 90,646 head or 9.3% of the total market. Saudi Arabia is a 
relatively new market for Australian live cattle, taking 54,354 head in 
2002. China is also a new market for Australian live cattle, importing 9372 
head in 2002. 
Saudi Arabia is Australia’s largest market for live sheep, importing 1.89 
million head worth A$128.6 million and representing a third (30.8%) of 
total live sheep exports in 2002. Kuwait is the second largest market 
(25.5% of total live sheep exports) taking 1.57 million head worth 
A$100.9 million. The United Arab Emirates is the fourth largest market 
for live sheep, taking 446,421 head worth A$29.7 million (LiveCorp 
2003). China is a very small market for live sheep exports. 
 
3.3 The bluetongue problem
 
Bluetongue is an insect-borne viral disease, of sheep primarily. It is very 
rare in cattle. It is also known as sore muzzle, pseudo foot-and-mouth 
disease and muzzle disease. Bluetongue disease is caused by orbiviruses 
in the family Reoviridae. These viruses occur throughout the world. 












are the primary vectors of the disease, which is common in 
tropical, subtropical, and temperate climates. 
While virus transmission is predominately by mosquitoes, some 
experimental studies have demonstrated that ticks might also be vectors. Its 
transmission in semen is not considered to be significant (Stott 1998). The 
virus is present throughout Africa, the Middle East, India, China, the United 
States, Mexico and southern Europe. Bluetongue virus infection, without  
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clinical disease, is present in Southeast Asia, Papua New Guinea, northern 
South America and northern Australia (Stott 1998). Several types of the 
bluetongue virus are present in Australia, but natural bluetongue disease has 




Outbreaks of bluetongue disease in sheep in China (1979–1997). Source: N. Zhang (pers. comm.)
 
The disease was first reported in China in 1979, at a sheep breeding farm 
in northern Yunnan. Since this initial recording, outbreaks have been 
observed in Hubei, Anhui, Sichuan, Jiangsu and Shanxi. While the virus 
has been isolated in Inner Mongolia and Xinjiang, there have been no 
clinical outbreaks there. Not all strains of bluetongue that infect sheep 
cause clinical disease. In some flocks, no clinical symptoms are apparent, 
whereas in other flocks infected by the same virus up to 30% of animals 
may develop signs of disease. Stott (1998) describes the disease as being 
characterised by fever, widespread haemorrhages of the oral and nasal 
tissue, salivation and nasal discharge. Lameness due to swelling of the 
hoofs, and loss of condition due to reduced feed consumption, may also be 
symptoms of this disease. Table 1 gives the numbers of clinical cases of 
bluetongue associated with each outbreak in China. 
Morbidity from bluetongue can reach 100% (Stott 1998). Infected animals 
may recover within periods of a few days to a fortnight. Nevertheless, 
even in the cases where the sheep recovers from the disease, high fever 
may have resulted in a reduction in the strength of wool produced. The 
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processing, as weaker wool can break during spinning. Hence, farmers 
could face a price penalty for tender wool as a direct result of their animals 
contracting the disease. In cattle, the symptoms of bluetongue infection 




  Numbers of cases of bluetongue disease occurring during outbreaks in various provinces of China 
 
between 1979 and 1997. 
 
Bluetongue virus is typically managed by vaccination. A modified-live 
(attenuated) virus vaccine has typically been used. Because of the large 
number of bluetongue serotypes and cross-protection between 
serotypes, vaccination has variable efficacy. The serotypes incorporated 
into the vaccine must be the same as those causing infection in the field 
(Stott 1998). Vaccination of pregnant ewes can sometimes cause 
abortion.
Development of rapid ELISA diagnostics as part of the ACIAR project 
will help authorities in China better match live vaccines with field strains, 
and the potential for outbreaks will be reduced. As a result of the 
widespread vaccination campaign in the country, no outbreaks of 
bluetongue have been recorded in China since 1997. During the period of 
widespread outbreaks — typically on government breeding stations — 
many exotic sheep were being imported to improve the national flock. 
With a fall in the world wool price, this activity declined. Consequently, 
fewer exotic animals were being exposed to, or transmitting, the virus, and 
the number of cases declined. With a return to higher wool prices, the 
demand for exotic sheep will likely return and the potential for disease 
outbreaks will increase. Enhanced diagnostic capacity will help to manage 
the disease.
 
3.4  The bovine ephemeral fever problem
 
Bovine ephemeral fever is a non-contagious insect-borne viral disease of 
cattle and water buffaloes. It is also known as three-day sickness, bovine 
epizootic fever, three-day stiff sickness and dragon boat disease. The 
disease was first reported in South Africa in 1906 and is present 
throughout Africa, southern Asia, southern and central China, southern 
 
Year of outbreak
1979–80 1984–89 1987–89 1988–89 1990–91 1993–97
Province Yunnan Hubei Anhui Sichuan Jiangsu Shanxi
Cases 430 1837 6 406 130 4
 
Sources: St George and Kegao (1996); N. Zhang (pers. comm.) 
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Japan, Southeast Asia and Australia. There have been no reports of BEF in 
Europe or the Americas (St George 1998).
The distribution of BEF in China is shown in Figure 3. It is evident that 
major epidemics have been reported in Guangdong province of southern 
China, Zhejiang and Shandong provinces of central China, and Liaoning 
province in northern China. Clinical cases of the disease have been 
reported in several other provinces marked on the figure. Years in which 




  Outbreaks of bovine ephemeral fever in China, 1955–1991. Darker shaded areas indicate provinces 
 
where major epidemics have occurred. Source: ACIAR Project AS1/1984/055 termination report.
 
St George (1998) notes that clinical signs of infection by BEF include 
accelerated heart and respiratory rates, anorexia, nasal and ocular 
discharges, salivation, muscle twitching stiffness and/or lameness. In 
some cases, animals may not be able to rise and they lose reflexes. The 
majority of cases, especially those in young cattle, are mild to moderate, 
and recovery is apparent after a few days. Lactating cows, bulls and fat 
steers suffer the most severe reaction to infection (St George 1998). 
Complications are possible in a minority of cases. These may include 
death, paralysis, temporary infertility and abortion. Milk production is 
reduced in infected animals, typically resulting in a 10–15% loss of 
production (Theodoridis et al. 1973; Davis et al. 1975). 
The disease is responsive to anti-inflammatory drugs. Infected animals 
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animals are immune to subsequent challenge. With this immune response 
in mind, vaccines have been produced in South Africa, Japan and 
Australia. These vaccines afford protection against laboratory challenge, 
but field efficacy is variable. A killed vaccine has been developed in China 
and is thought to afford good protection. The vaccine was elaborated 
following the development of a diagnostic method and cell culture 
procedure as part of the ACIAR projects. It is used by many intensive 
cattle enterprises. The economic benefits of the introduction and use of 
this vaccine in China are quantified in Section 4. 
 
3.5  Benefits associated with improved animal disease 
management 
 
Development of improved diagnostic capacity has improved both 
bluetongue and BEF management. To recapitulate: in the case of BEF, a 
killed vaccine has been developed and adopted in intensive cattle 
production enterprises throughout China. In the case of bluetongue, the 
development of diagnostic tools has facilitated more accurate disease 
surveillance and diagnosis, leading to improved matching of vaccines to 
field strains of the disease. No cases of bluetongue have been recorded in 
China since the end of the projects. Additionally, the isolation of new 
strains of BEF virus in China has allowed banking of variants that will 
permit rapid development of new vaccine strains should the virus change 
due to genetic drift. 
To date, most project benefits have been captured by livestock producers in 
China. The economic benefits are calculated in the next section. However, 
before quantifying these benefits using benefit–cost analysis, the benefits to 
the poorest people are discussed using the ACIAR poverty-reduction 
framework. As part of this framework, the criteria used to assess the poverty 








Years of major bovine ephemeral fever epidemics in various provinces of China
 
Province
Dalian, Liaoning Hangzhou, Zhejiang Jinan, Shandong Guangzhou, Guangdong
1983 1955, 1958, 1965, 1871, 
1983, 1987, 1988
1955, 1958, 1966, 1970, 
1976, 1983, 1987
1955, 1962, 1966, 1971, 1972, 
1976, 1977, 1978, 1979, 1983, 
1985, 1987, 1988
 
Source: ACIAR Project AS1/1984/055 termination report. 
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provision of health benefits
 
  provision of environmental benefits that improve sustainability of 
income generation and enhance quality of life
  promotion of pro-poor policies and institutional change
  empowerment of poor people particularly women and children
  reduction in the impact of unforeseen events.
Possibly the greatest poverty benefit from the development of diagnostic 
tools and vaccines is in terms of reducing unforeseen events, with 
measures to reduce the incidence of major disease epidemics bringing 
major benefits. During outbreaks of BEF in Guangdong province of 
southern China, Zhejiang and Shandong provinces of central China and 
Liaoning province in northern China, large numbers of animals suffered 
mortality and other production losses — such as the inability to perform 
traction (Wenbin 1993). Enhanced animal health and reduced disease 
incidence will moderate fluctuations in farm incomes.
4 Benefit–cost analysis of the projects
As noted earlier, most project benefits have been captured by livestock 
producers in China, because BEF vaccines partly developed as a result of 
ACIAR-supported research have been commercialised in that country, 
and because of the reduced incidence of bluetongue in sheep. The 
economic value of these benefits is calculated, along with possible 
benefits to Australian exporters through a reduction in the requirements 
for testing animals destined for export to China. This section gives: first, 
the evaluation framework; second, an outline of the project costs; and 
third, the assumptions behind the economic analysis. Finally, the results of 
the benefit–cost and sensitivity analyses are presented. 
4.1 Evaluation  framework
Benefits and costs are discounted using a 5% discount rate for project 
benefits that have already been realised and for a 30-year projection. Net 
present value (NPV) and benefit–cost ratio (BCR) investment criteria are 
also presented for each scenario. A BCR greater than one and a positive 
NPV indicate that project benefits are greater than project costs.20
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4.2 Project  costs
The costs associated with project activities in China, Malaysia and 
Australia are presented in Table 3. The total costs of these activities were 
approximately A$3.1 million in nominal terms. ACIAR financial support 
over the period amounted to A$1.5 million. In the benefit–cost analysis 
that follows, these costs are translated into 2001 dollar terms using 
adjustment factors for inflation. 
Table 3.  Annual costs of the research on bluetongue disease and bovine ephemeral fever.
4.3 Key assumptions
In this section, the assumptions underpinning the calculation of project 
benefits are provided. Key economic impacts that are quantified include 
the additional costs of BEF vaccination, benefits associated with reduced 
incidence of BEF in dairy herds, benefits attributable to reduced incidence 
of bluetongue in sheep, and potential benefits to Australian exporters from 
reduced animal testing and quarantine costs. As the growth that was 
expected in the Malaysian small ruminant flock has not occurred, any 
possible benefits associated with improved bluetongue management in 
that country are not included. 






1986 115,139 42,670 157,809
1987 102,446 41,020 143,466
1988 80,280 48,870 129,150
1989 297,865 90,000 387,865
1990 0 0 0
1991 6,088 0 6,088
1992 24,120 0 24,120
1993 0 0 0
1994 211,259 319,000 530,259
1995 222,685 558,500 781,185
1996 245,865 425,004 670,869
1997 157,952 142,500 300,452
Total (million) 1.5 1.7 3.121
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Costs of BEF vaccination
Research conducted as part of the projects with the Harbin Veterinary 
Research Institute led to the development of a killed vaccine for BEF that 
is now widely used in China. Currently, around 100,000 animals are 
vaccinated per year, primarily in the dairy cattle sector. The vaccine costs 
about A$2 per dose and is thought to be effective. The cost of vaccination 
is included in Table 4, along with vaccination adoption assumptions. It is 
assumed that the vaccine was launched in 1995, and that it took 5 years for 
the vaccine to reach the current, maximum level of adoption.
Table 4.  Summary of assumptions made in the economic analysis of the results of bluetongue and bovine 
ephemeral disease (BEF) research in China.
Parameter Value Source
Vaccination costs Approx. A$0.25m per 
annum
Consultant estimate based on data provided by scientists at the 
Harbin Veterinary Research Institute. An estimated 100,000 animals 
are vaccinated each year. Calves receive multiple doses, and adult 
cattle get annual booster vaccinations.
Year BEF vaccine was 
commercialised
1995  Consultant estimate based on consultation with scientists at the 
Harbin Veterinary Research Institute.
Years to maximum 
adoption of BEF vaccine
5 Consultant estimate based on consultation with scientists at the 
Harbin Veterinary Research Institute. 
Reduced number of (in 
milk) dairy cattle BEF cases
3000 per year Consultant estimate based on vaccination coverage rates outlined by 
scientists at the Harbin Veterinary Research Institute and BEF 
prevalence outlined by Wenbin (1993). Dairy cows are highly 
susceptible to BEF.
Average farm-gate price for 
milk 
A$0.40 per kg Consultant estimate derived from CDIC (2003)
Average milk production 
per cow per year
4000 kg Consultant estimate derived from Tuan (1987). Assumes high 
producing animals would receive vaccine.
Lost milk production per 
BEF infected case
600 10–15% taken from Theodoridis et al. (1973) and Davis et al. (1975). 
Reduced number of 
bluetongue cases in sheep
200 per year Consultant estimate based on outbreaks levels reported in St George 
and Kegao (1996)
Cost of replacing sheep  A$50 per head Consultant estimate 
Live animals exported to 
China
20,000 per year Consultant estimate. Difficult to determine longer term market 
volume as Australian Bureau of Statistics figures show a rapid increase 
in trade over the last few years.
Cost saving from changed 
regulations
A$10 per head Consultant estimate based on the number of bluetongue tests that 
have to be performed being reduced by one and the diagnostic test 
costs in NSW (NSW Agriculture 2003).
Probability of regulations 
being changed in 2005
40% Consultant estimate22
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The level of BEF killed-vaccine adoption could increase in the future, if 
there is another major outbreak of BEF. The recent increases in the size of 
the dairy herd, and corresponding build-up of high-value cattle that are 
susceptible to the disease, could result in increased demand for the BEF 
vaccine. Given, however, that there has not been a major outbreak since 
the end of the ACIAR projects in the early 1990s, it is difficult to predict if 
and when such demand might appear. In the absence of precise 
information about BEF epidemiology and consequent demand, current 
levels of adoption are projected across the evaluation time frame.
Reduced incidence of BEF in dairy cattle
The dairy industry in China has been growing, and infection of dairy cattle 
by BEF causes considerable economic loss. Field work conducted within 
the ACIAR projects found considerable losses due to the disease at milk 
factory farms. Given the high losses suffered by animals affected by BEF, 
it is assumed that dairy farms are the principal purchasers of the vaccine. 
During the period of acute infection, animals suffer fever, and milk 
production is reduced by 600 kg per year per infected animal (Theodoridis 
et al. 1973; Davis et al. 1975). It is estimated that the BEF vaccine 
developed as part of the ACIAR-supported projects would result in 3000 
fewer cases of BEF across China than would have occurred without the 
research. 
Reduced incidence of bluetongue in sheep
Within China most outbreaks have been observed on government sheep-
breeding farms and have involved exotic breeds imported to increase the 
productivity of the flock. Activity associated with exotic importation was 
at its height during the late 1980s when world wool prices were high and 
sheep raising was profitable. At this time, many sheep were being 
imported into China and bluetongue outbreaks were evident. In response 
to outbreaks, the Chinese authorities implemented widespread 
vaccination, and infected stock were slaughtered. During the peak of the 
disease, 1837 cases were reported at Hubei during 1984–89, while 406 
were reported in Sichuan. With a return to higher wool prices, it is likely 
that exotic sheep will again be imported and bluetongue diagnostic 
capacity developed as part of the ACIAR projects will help to identify the 
serotypes of the virus involved in the outbreaks, so enhancing the targeting 
of any vaccination. Given there has been no bluetongue outbreak since the 
end of the ACIAR projects, it is assumed that an average of 200 cases per 
year will be avoided as a result of the diagnostic capacity development 
financed by ACIAR. 23
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Reduced costs of animal exports
China has very stringent import requirements, and several tests involving 
bluetongue have to be performed before animals will be accepted for 
importation. Research into the types of serotypes found in China and 
Australia will help to rationalise the number of tests required by Australian 
exporters before shipment. It is assumed that testing requirements will be 
reduced by one bluetongue test per live animal destined for China as a 
result of research confirming the presence of certain serotypes in China. 
Consequently, the exporter will save A$10 per head (the approximate cost 
of a diagnostic test by NSW Agriculture (NSW Agriculture 2003)). 
Currently, Australian exports of live cattle to China are growing 
exponentially. For the purposes of the analysis, it is assumed that, on 
average, the export of live cattle will total 20,000 head per year from 
2005–2015 (market growth evident in Figure 1) and that there is a 40% 
chance of Chinese import regulations being modified from 2005 onwards. 
Given the political nature of trade regulations, the probability of testing 
being modified is estimated to be relatively low.
4.4 Results
The NPV of enhanced animal disease control and diagnostic capability to 
China producers and Australian exporters is forecast to be $A4.6 million 
(expressed in 2001 dollar terms). The corresponding BCR is estimated to 
be 2.3:1 and the internal rate of return 13%. A BCR of this magnitude 
suggests that, for each dollar allocated to the projects, 2.3 dollars of project 
benefits will be generated. The flow of annual costs and benefits across the 
30-year evaluation period is given in Table 5 and Figure 4.
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Table 5. Benefit–cost analysis of research projects on bluetongue disease and bovine ephemeral fever. 
Period Benefits Research Totals
























value     
(A$2001)
1 1986 0.00 0.00 0.00 1.74 0.00 0.27 –0.27 –0.57
2 1987 0.00 0.00 0.00 1.61 0.00 0.23 –0.23 –0.46
3 1988 0.00 0.00 0.00 1.50 0.00 0.19 –0.19 –0.37
4 1989 0.00 0.00 0.00 1.40 0.00 0.54 –0.54 –0.98
5 1990 0.00 0.00 0.00 1.30 0.00 0.00 0.00 0.00
6 1991 0.00 0.00 0.00 1.26 0.00 0.08 –0.08 –0.12
7 1992 0.00 0.00 0.00 1.25 0.00 0.03 –0.03 –0.05
8 1993 0.00 0.00 0.00 1.23 0.00 0.00 0.00 0.00
9 1994 0.00 0.00 0.00 1.20 0.00 0.18 –0.18 –0.26
10 1995 0.05 0.15 0.00 1.15 0.11 0.26 –0.15 –0.20
11 1996 0.10 0.29 0.00 1.12 0.22 0.22 –0.01 –0.01
12 1997 0.15 0.44 0.00 1.11 0.32 0.10 0.22 0.27
13 1998 0.20 0.58 0.00 1.11 0.43 0.00 0.43 0.49
14 1999 0.25 0.73 0.00 1.09 0.52 0.00 0.52 0.58
15 2000 0.25 0.73 0.00 1.04 0.50 0.00 0.50 0.52
16 2001 0.25 0.73 0.00 1.00 0.48 0.00 0.48 0.48
17 2002 0.25 0.73 0.00 1.00 0.48 0.00 0.48 0.46
18 2003 0.25 0.73 0.00 1.00 0.48 0.00 0.48 0.44
19 2004 0.25 0.73 0.00 1.00 0.48 0.00 0.48 0.41
20 2005 0.25 0.73 0.08 1.00 0.56 0.00 0.56 0.46
21 2006 0.25 0.73 0.08 1.00 0.56 0.00 0.56 0.44
22 2007 0.25 0.73 0.08 1.00 0.56 0.00 0.56 0.42
23 2008 0.25 0.73 0.08 1.00 0.56 0.00 0.56 0.40
24 2009 0.25 0.73 0.08 1.00 0.56 0.00 0.56 0.38
25 2010 0.25 0.73 0.08 1.00 0.56 0.00 0.56 0.36
26 2011 0.25 0.73 0.08 1.00 0.56 0.00 0.56 0.34
27 2012 0.25 0.73 0.08 1.00 0.56 0.00 0.56 0.33
28 2013 0.25 0.73 0.08 1.00 0.56 0.00 0.56 0.31
29 2014 0.25 0.73 0.08 1.00 0.56 0.00 0.56 0.30
30 2015 0.25 0.73 0.08 1.00 0.56 0.00 0.56 0.28
Total 4.75 13.87 0.88 10.17 2.12 8.06 4.6425
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Table 6 gives the present values of project benefits to Australia and China 
for benefits realised to date and projected forward. If only benefits to date 
are accounted for, then the ACIAR animal disease projects are calculated 
to generate a present value of benefits of A$3.3 million, all of which are 
captured by Chinese producers. In contrast, if possible benefits to Chinese 
producers and Australian exporters are incorporated in the projection, then 
a present value of benefits of A$8.2 million would accrue to the projects. 
It is estimated that Chinese producers will capture approximately 90% of 
the total present value of projected benefits.
Table 6.  Present value of benefits (A$m) of bluetongue disease and bovine ephemeral fever research projects.
4.5 Sensitivity  analysis
A number of estimates have been included in the analysis in relation to the 
impact of enhanced diagnostic capability and vaccine development in 
China and Australia. These estimates have been made using the best 
available information, but are uncertain. Sensitivity analysis is undertaken 
in this section to determine which parameters have a significant impact 
upon the estimated economic returns of the projects. 
4.5.1 Discount  rate
A 5% discount rate was included in the analysis for baseline economic 
return calculations. The magnitude of this parameter may vary for 
different investors. Table 7 outlines the sensitivity of NPV and BCRs to 
the discount rate applied.
Table 7. Sensitivity of bluetongue disease and bovine ephemeral fever research investment criteria to discount 
rate.
Source of benefits Present value of benefits to 
China
(A$m)
Present value of benefits to 
Australia
(A$m)
Total benefits (to 2003) 3.3 0.0
Total benefits (projected forward) 7.6 0.6
Benefits (forward projection)  Discount rate
0% 5% 10%
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Higher BCRs and NPVs are calculated at lower discount rates. The 
difference between NPVs at 0 and 5% discount rates for the projection is 
calculated to be A$3.5 million.
4.5.2 Reduced live animal export costs
The rationalisation of Chinese animal testing and quarantine import 
requirements is a potential benefit of the projects. At present, these 
requirements are very stringent and impose a substantial cost on animal 
exporters. If these costs were reduced, exporters would reap significant 
benefits. Nevertheless, there is a degree of uncertainty about the value of 
any cost savings, as import regulations are currently being negotiated. The 
sensitivity of investment criteria to export cost savings is provided in 
Table 8. It is evident that a 10% further increase in the cost saving would 
generate an addition A$0.1 million in net present value.
Table 8.  Sensitivity of animal disease research investment criteria to export cost saving.
5 Conclusions
Enhanced bluetongue disease diagnostic capability has been established in 
China, and a killed BEF vaccine has been developed as a result of research 
conducted within ACIAR-supported projects. These developments have 
led to reduced incidence of the insect-borne bluetongue and BEF viruses. 
Such a reduction increases animal productivity in China through reduced 
mortality and increased production of milk and meat. The potential for 
introducing genetically superior livestock into the national Chinese flock 
is also enhanced through the development of capacity to manage these 
diseases, which affect exotic breeds in particular.
In addition, China has stringent import requirements for livestock. 
Diagnostic capacity and epidemiological research conducted within the 
projects have identified the serotypes of the viruses present in China and 
Australia. This information is likely to lead to rationalisation of Chinese 
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likely to increase, and the costs of exotic animal purchases by Chinese 
livestock producers and merchants to fall. The estimated NPV of the 
returns to Australia and China from the ACIAR-supported projects on 
BEF and bluetongue is A$4.6 million and the corresponding BCR 2.3:1. 
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